Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Operating Leases (2019 - 2026)

Bioceres Crop Solutions' Operating Leases history spans 8 years, with the latest figure at $8.6 million for Q1 2026.

  • On a quarterly basis, Operating Leases changed N/A to $8.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $8.6 million, a N/A change, with the full-year FY2025 number at $9.5 million, up 16.4% from a year prior.
  • Operating Leases hit $8.6 million in Q1 2026 for Bioceres Crop Solutions, down from $9.5 million in the prior quarter.
  • Over the last five years, Operating Leases for BIOX hit a ceiling of $10.3 million in Q2 2022 and a floor of $8.2 million in Q2 2024.
  • Historically, Operating Leases has averaged $9.3 million across 5 years, with a median of $9.5 million in 2025.
  • Biggest five-year swings in Operating Leases: surged 2548.09% in 2022 and later dropped 18.63% in 2024.
  • Tracing BIOX's Operating Leases over 5 years: stood at $10.3 million in 2022, then fell by 2.98% to $10.0 million in 2023, then fell by 18.63% to $8.2 million in 2024, then rose by 16.4% to $9.5 million in 2025, then decreased by 9.47% to $8.6 million in 2026.
  • Business Quant data shows Operating Leases for BIOX at $8.6 million in Q1 2026, $9.5 million in Q2 2025, and $8.2 million in Q2 2024.